Foundayo vs. Compounded Semaglutide: Cost, Efficacy, and the Compounding Patient's Calculus
In April 2026, the FDA approved Foundayo (orforglipron) — the first oral GLP-1 pill with no food, water, or timing restrictions. For patients currently on compounded semaglutide, this creates a new question: is it time to switch to an FDA-approved oral option?
Here's a direct comparison across the factors that actually matter.
Head-to-Head Comparison
| Factor | Foundayo (Orforglipron) | Compounded Injectable Semaglutide |
|---|---|---|
| FDA approved | Yes | No |
| Format | Daily pill | Weekly injection |
| Weight loss (72wk) | 7.5–11.2% | ~15% (same molecule as Wegovy) |
| Food/water rules | None | N/A (injection) |
| Storage | Room temp (protect from light) | Refrigerate |
| Regulatory risk | None — FDA-approved | Ongoing — 503B exclusion pending, 503A under scrutiny |
| Monthly cost | Brand pricing (TBD) | $99–$299/mo |
| Medicare Bridge eligible | Yes ($50/mo) | No |
| Insurance coverage | Expanding | None |
When Compounded Still Wins
Cost without insurance: At $99–$149/month through telehealth providers, compounded semaglutide remains significantly cheaper than any brand-name GLP-1 without insurance coverage. If you're paying cash and Foundayo's brand pricing lands at $500+/month (likely), the math still favors compounded.
Weight loss efficacy: Compounded semaglutide delivers the same molecule as Wegovy, which achieves ~15% weight loss at 72 weeks. Foundayo's maximum was 11.2%. For patients who need maximum weight reduction, injectable semaglutide still delivers more.
Dose flexibility: Compounding pharmacies can create custom titration schedules and doses not available in commercial products. Some patients benefit from non-standard dose steps.
When Foundayo Wins
Regulatory certainty: No risk of supply disruption from regulatory action. The compounded GLP-1 landscape is shifting fast — Foundayo will be available regardless.
No injections: For needle-averse patients, a daily pill eliminates the biggest barrier to starting treatment.
Medicare coverage: Starting July 1, 2026, Medicare covers Foundayo at $50/month through the GLP-1 Bridge. Compounded medications are excluded.
Travel convenience: No refrigeration, no sharps, no explaining vials at airport security. Just a pill bottle.
The Decision Framework
Compounded Providers to Compare
Explore the program’s treatment pathways and ask which medication type, pharmacy, enrollment requirements and recurring charges apply to your location.
Explore GobyMeds ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.Explore available weight-management program types and confirm the exact medication, pharmacy and recurring charges.
Explore GobyMeds ↗Medication, legal availability, provider credentials and full price require verification; compounded medications are not FDA-approved.Brand-Name Access
Review consultation options, program fees, medication access, insurance considerations and what happens after your first appointment.
Explore Sesame Care ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.Compare Compounding Pharmacy Providers
See pricing, pharmacy type, and what's included — side by side.
Compare Providers →